Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oxis on Mucociliary Clearance in COPD
2005-000366-39Phase 4Completed
- Sponsor
- Inamed
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of formoterol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Inamed. Primary endpoint: Particle retention after 2 hours. Started Mar 2005; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-000366-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000366-39.